Fox News reported that Dr. Heidi Overton, a Food and Drug Administration nominee, committed to a timeline for a delayed mifepristone safety study, according to a summary of the exclusive report. The Fox News headline says the nominee "vows new abortion pill safety review" after pressure from Sen. Josh Hawley.

According to the summary, Fox News attributed the commitment to Sen. Josh Hawley's office, which said the nominee agreed to the timeline. The summary does not say when the timeline was set, how long it runs, or what the delayed study would examine.

The report describes the study as delayed, but the summary does not give a reason for the delay or identify the scientists or agencies that would carry out the review. The summary does not include a statement from the nominee on the timeline.

The Fox News item is labeled an exclusive, and the feed listing for it did not include an author name. The summary does not indicate whether the Food and Drug Administration responded to the account, and no other outlet's reporting on the commitment was available for this story.

Mifepristone is named in the Fox News headline and summary as the subject of the delayed study. The nominee's commitment, as described in those materials, concerns a timeline for that study and a review of the drug's safety, and the materials give no further detail on either point.

Sources: Fox News: EXCLUSIVE: Trump’s FDA nominee vows new abortion pill safety review after pressure from Sen Hawley.